The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era-Reference-Cited by-同舟云学术

The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era

Published:2022-09-14 Issue: Volume:12 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Li Zheng,Hu Yue,Zeng Ming,Hu Qinyong,Ye Fei,Liu Ruifeng,Cai Hongyi,Li Qiang,Wang Xiaohu

Abstract

The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile.

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Health Commission of Sichuan Province

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference43 articles.

1. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21;Wang;Lancet,2022

2. Excess mortality in wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries;Liu;Bmj,2021

3. WHO time-line COVID-19

4. WHO coronavirus disease (COVID-19) situation dashboard

5. Historical and clinical aspects of the 1918 H1N1 pandemic in the united states;Jester;Virology,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets;Clinical Epigenetics;2023-06-12